Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com.
The Variation Analysis of Clinical, Biological and Epidemiological Characteristics Among the COVID-19 Confirmed Patients with Different Clinical Staging
12 Pages Posted: 30 Mar 2020
More...Abstract
Background: Since December 2019, Novel coronavirus pneumonia has been reported from Wuhan, China, we try to analysis the clinical, biological and epidemiological characteristics among the COVID-19 confirmed patients, and find the variation of different clinical staging.
Methods: We conducted a retrospective study on all patients with confirmed COVID-19 who were admitted for care at Fifth Medical center of PLA General Hospital in Peking, we used the respiratory or blood samples by RT-PCR or highly homologous with COVID-19 by sequencing of virus genes is positive result was the diagnosis standard for Novel Coronavirus Pneumonia.
Results: 55 patients (23 female and 32 male) clinical, biological and epidemiological characteristic were collected in our study, the age of them ranging from 3 to 85 years with the mean age was 44.93 years (SD=17.86). 34/55 had travelled or lived in Wuhan or Hubei, and 29/55 had contact with confirmed patients, 4 patients had no the travel or contact history. The most confirmed patients had the fever (47/55) and cough (28/55), fever (85.45%), pneumonia (65.45%), and cough (50.91%) were important sign of COVID-19, the time from exposure to morbidity were ranging from 1 to 22 days with mean time was 7.84 (4.78) days. IL-6 (56.85%), Lactic acid (48.89%), CPR (41.82%), and ESR (39.22%) were significant improvement than normal, and CD4 (44.73%), T-LYM (28.21%), B-LYMV (25.71%), NK-LYMV (25.71%), and CD8 (21.05%) had a decrease than normal.
Conclusion: All people are susceptible for COVID-19, most confirmed patients had the travel history to Wuhan or contact history with confirmed patient, poor immunity had a higher risk to get COVID-19 than others, the most common clinical symptoms are fever, cough, and weakness, the mean incubation in our study are 7.84 days, the confirmed patients usually had the IL-6, Lactic acid, CPR, and ESR. Elder and had anamnesis patients had the high risk of deterioration than others, and the clinical staging and complication had highly correlated.
Funding Statement: None.
Declaration of Interests: None.
Ethics Approval Statement: The study was approved by the Fifth Medical center of PLA General Hospital.
Keywords: Clinical characteristic; Biochemical characteristic; epidemiological characteristic; COVID-19; Novel coronavirus pneumonia; 2019-Ncov
Suggested Citation: Suggested Citation